{"id":"W4410821448","doi":"10.1200/jco.2025.43.16_suppl.4500","title":"Nivolumab plus ipilimumab (NIVO+IPI) vs gemcitabine-carboplatin (gem-carbo) chemotherapy for previously untreated unresectable or metastatic urothelial carcinoma (mUC): Final results for cisplatin-ineligible patients from the CheckMate 901 trial.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Gemcitabine; Nivolumab; Ipilimumab; Carboplatin; Metastatic Urothelial Carcinoma; Cisplatin; Chemotherapy; Internal medicine; Oncology; Urology; Urothelial carcinoma; Bladder cancer; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001815083,0.0009361946,0.001261959,0.0002821104,0.0002157595,0.000988742,0.0007509513,0.001025941,0.003616238],"category_scores_gemma":[0.001223688,0.0003463307,0.001636545,0.0003026316,0.0005057072,0.0006007428,0.0003801133,0.002102129,0.00054308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001038642,"about_ca_system_score_gemma":0.0008327755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163631,"about_ca_topic_score_gemma":0.003841728,"domain_scores_codex":[0.9995492,0.0002732424,0.00002327609,0.000058221,0.00002839953,0.00006775566],"domain_scores_gemma":[0.9993818,0.0001618358,0.0001744111,0.00004575458,0.00002485755,0.0002112908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9524635,0.004784698,0.001859122,0.0008233365,0.001535033,0.00003744027,0.00007075784,0.001104176,0.004116592,0.0001199698,0.001532637,0.03155286],"study_design_scores_gemma":[0.8009347,0.1792719,0.01109924,0.000152374,0.002748611,0.0001268146,0.00005525892,0.001371375,0.001627432,0.0003323396,0.002251879,0.00002799729],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876515,0.005693849,0.0003240599,0.0005384099,0.0002633038,0.00147158,0.001314091,0.00006842683,0.002674734],"genre_scores_gemma":[0.9930643,0.001638311,0.0006291961,0.0006511314,0.0001289672,0.0009652837,0.001332606,0.00001991579,0.001570191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003616238,"threshold_uncertainty_score":0.01209754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1410537168996208,"score_gpt":0.4486486768325521,"score_spread":0.3075949599329313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}